Rodrigo Valdes-Rodriguez, MD
Dermatopathology · San Antonio, TXNPI 1518311778
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $7,110 of the $9,732 with a category attached, or 73.1%. Galderma Laboratories, L.p. accounts for 75.1% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2024 at $8,110 and has fallen 97.3% since, to $222 in 2025.
Across 93 payments — averaging $104.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$7K
- AbbVie$380
- Dermavant Sciences, Inc.$366
- Johnson & Johnson$348
- E.r. Squibb & Sons, L.L.C.$307
- Novartis$197
- plus $825 from 16 others
What the payments were for
- Consulting fees$7,11073%
- Food & beverage$2,43925%
- Education$1832%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 7 | $7,308 |
| AbbVie | 9 | $380 |
| Dermavant Sciences, Inc. | 20 | $366 |
| Johnson & Johnson | 10 | $348 |
| E.r. Squibb & Sons, L.L.C. | 12 | $307 |
| Novartis | 3 | $197 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $142 |
| Regeneron Healthcare Solutions, Inc. | 6 | $117 |
| Incyte Corporation | 3 | $104 |
| Krystal Biotech Inc | 4 | $76 |
| Lilly USA, LLC | 3 | $73 |
| Pfizer | 3 | $57 |
| LEO Pharma Inc. | 2 | $48 |
| Regeneron | 1 | $41 |
| Sun Pharmaceutical Industries Inc. | 2 | $37 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $23 |
| Genentech USA, Inc. | 1 | $21 |
| Biofrontera Inc. | 1 | $21 |
| Arcutis Biotherapeutics, Inc. | 1 | $21 |
| Kerecis Limited | 1 | $21 |
| Sanofi | 1 | $15 |
| Organon | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,732 in reported general payments places this provider in the 75th percentile of 54 dermatopathology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 13 | $53,441 |
| Clobetasol Propionate | 152 | $6,737 |
| Acitretin | 12 | $4,532 |
| Tacrolimus | 24 | $3,159 |
| Fluorouracil | 26 | $2,109 |
| Tretinoin | 21 | $1,709 |
| Triamcinolone Acetonide | 92 | $1,653 |
| Ketoconazole | 74 | $1,278 |
| Metronidazole | 14 | $899 |
| Betamethasone Dipropionate | 15 | $866 |
| Clindamycin Phosphate | 24 | $807 |
| Mycophenolate Mofetil | 15 | $639 |
| Doxycycline Hyclate | 25 | $637 |
| Ammonium Lactate | 35 | $637 |
| Hydrocortisone | 33 | $487 |
Paid to pharmacies, not to this prescriber.
Other dermatopathology in San Antonio
- Mary AltmeyerSan Antonio$9K
- Patricia MillerSan Antonio$5K
- William SchaffenburgSan Antonio$1K
- Thomas DavisSan Antonio$729
- Margaret AbuzeidSan Antonio$418
- Andrea HawsSan Antonio$417
- Charles StevensSan Antonio$130
- Abigail LeeSan Antonio$24
- William BabcockSan Antonio$15
- Angela MooreArlington$423K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.